Literature DB >> 25678610

Pulmonary leucostasis in a patient with chronic lymphocytic leukaemia.

Christina Awad1, Rajul Parikh2, Yara Fardous2.   

Abstract

A 71-year-old woman with no chronic medical problems presented to the emergency room with a 24-month history of chronic non-productive cough, malaise, increasing fatigue and weight loss. On physical examination, she had significant cervical and axillary lymphadenopathy with no organomegaly. She was diagnosed with chronic lymphocytic leukaemia (CLL) due to her lymphocyte count of 1789.4×10(9)/L on admission. A few days after hospitalisation, she developed respiratory failure requiring intubation. A chest X-ray showed interstitial markings. The abnormally high number of mature lymphocytes could have caused leucostasis in the lungs of this patient with CLL. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25678610      PMCID: PMC4330447          DOI: 10.1136/bcr-2014-205953

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

Authors:  Kirsten Fischer; Paula Cramer; Raymonde Busch; Sebastian Böttcher; Jasmin Bahlo; Jöerg Schubert; Karl H Pflüger; Silke Schott; Valentin Goede; Susanne Isfort; Julia von Tresckow; Anna-Maria Fink; Andreas Bühler; Dirk Winkler; Karl-Anton Kreuzer; Peter Staib; Matthias Ritgen; Michael Kneba; Hartmut Döhner; Barbara F Eichhorst; Michael Hallek; Stephan Stilgenbauer; Clemens-Martin Wendtner
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

2.  Current and emerging treatments for chronic lymphocytic leukaemia.

Authors:  Tadeusz Robak; Krzysztof Jamroziak; Pawel Robak
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 3.  Update in the management of chronic lymphocytic leukemia.

Authors:  Kami J Maddocks; Thomas S Lin
Journal:  J Hematol Oncol       Date:  2009-07-20       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.